AcuCort Renews US FDA Small Business Waiver for New Drug Applications

MT Newswires · 2d ago
03:58 AM EDT, 07/27/2026 (MT Newswires) -- AcuCort (ACUC.ST) said Monday its small business waiver was renewed by the US Food and Drug Administration. The waiver will exempt the Swedish pharmaceutical group from paying the 16 million kronor application fee for a new drug application.